Literature DB >> 26909131

Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.

Yu-Ping Xu1, Min Yang1.   

Abstract

Pancreatic cancer (PC) is a major health problem. Conventional imaging modalities show limited accuracy for reliable assessment of the tumor. Recent researches suggest that molecular imaging techniques with tracers provide more biologically relevant information and are benefit for the diagnosis of the cancer. In addition, radiopharmaceuticals also play more important roles in treatment of the disease. This review summaries the advancement of the radiolabeled compounds in the theranostics of PC.

Entities:  

Keywords:  Diagnosis; Pancreatic cancer; Positron emission tomography; Radiopharmaceuticals; Therapy

Year:  2016        PMID： 26909131      PMCID： PMC4753167          DOI： 10.4251/wjgo.v8.i2.165

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  99 in total

Review 1.  Rationale for the use of radiolabelled peptides in diagnosis and therapy.

Authors:  K P Koopmans; A W J M Glaudemans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

Review 2.  The role of molecular imaging in modern drug development.

Authors:  Lídia Cunha; Krisztián Szigeti; Domokos Mathé; Luís F Metello
Journal:  Drug Discov Today       Date:  2014-01-13       Impact factor: 7.851

3.  [Implantation brachytherapy with 32P-chromic phosphate-poly (L-lactide) delayed-release particles for prostate cancer in nude mice].

Authors:  Xing-Jun He; Rui-Peng Jia; Guo-Qiang Shao; Lu-Wei Xu; Zi-Zheng Wang; Pei-Lin Huang; Jian-Ping Wu; Jun Wang
Journal:  Zhonghua Nan Ke Xue       Date:  2010-10

Review 4.  PET/CT of cancer patients: part 1, pancreatic neoplasms.

Authors:  Elizabeth H Dibble; Dimitrios Karantanis; Gustavo Mercier; Patrick J Peller; Lisa A Kachnic; Rathan M Subramaniam
Journal:  AJR Am J Roentgenol       Date:  2012-11       Impact factor: 3.959

Review 5.  Positron emission tomography imaging of prostate cancer.

Authors:  Hao Hong; Yin Zhang; Jiangtao Sun; Weibo Cai
Journal:  Amino Acids       Date:  2009-11-28       Impact factor: 3.520

6.  Multimodal molecular imaging of integrin αvβ3 for in vivo detection of pancreatic cancer.

Authors:  Marija Trajkovic-Arsic; Pouyan Mohajerani; Athanasios Sarantopoulos; Evdokia Kalideris; Katja Steiger; Irene Esposito; Xiaopeng Ma; George Themelis; Neal Burton; Christoph W Michalski; Jörg Kleeff; Stefan Stangl; Ambros J Beer; Karolin Pohle; Hans-Jürgen Wester; Roland M Schmid; Rickmer Braren; Vasilis Ntziachristos; Jens T Siveke
Journal:  J Nucl Med       Date:  2014-02-18       Impact factor: 10.057

7.  Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4.

Authors:  Yuping Xu; Donghui Pan; Qing Xu; Chen Zhu; Lizhen Wang; Fei Chen; Runlin Yang; Shineng Luo; Min Yang
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-17       Impact factor: 4.553

8.  Role of PET/CT in the clinical management of locally advanced pancreatic cancer.

Authors:  Maria Picchio; Elisabetta Giovannini; Paolo Passoni; Elena Busnardo; Claudio Landoni; Giampiero Giovacchini; Valentino Bettinardi; Cinzia Crivellaro; Luigi Gianolli; Nadia Di Muzio; Cristina Messa
Journal:  Tumori       Date:  2012 Sep-Oct

9.  Intratumoral administration of holmium-166 acetylacetonate microspheres: antitumor efficacy and feasibility of multimodality imaging in renal cancer.

Authors:  Wouter Bult; Stephanie G C Kroeze; Mattijs Elschot; Peter R Seevinck; Freek J Beekman; Hugo W A M de Jong; Donald R A Uges; Jos G W Kosterink; Peter R Luijten; Wim E Hennink; Alfred D van het Schip; J L H Ruud Bosch; J Frank W Nijsen; Judith J M Jans
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

10.  Evaluation of an [(18)F]AlF-NOTA Analog of Exendin-4 for Imaging of GLP-1 Receptor in Insulinoma.

Authors:  Dale O Kiesewetter; Ning Guo; Jinxia Guo; Haokao Gao; Lei Zhu; Ying Ma; Gang Niu; Xiaoyuan Chen
Journal:  Theranostics       Date:  2012-10-17       Impact factor: 11.556
View more
  3 in total

Review 1.  Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.

Authors:  Zarin Nuzhat; Vyjayanthi Kinhal; Shayna Sharma; Gregory E Rice; Virendra Joshi; Carlos Salomon
Journal:  Oncotarget       Date:  2017-03-07

2.  Deoxyelephantopin induces apoptosis via oxidative stress and enhances gemcitabine sensitivity in vitro and in vivo through targeting the NF-κB signaling pathway in pancreatic cancer.

Authors:  Daolin Ji; Xiangyu Zhong; Peng Huang; Pengcheng Kang; Kaiming Leng; Wangyang Zheng; Zhidong Wang; Yi Xu; Yunfu Cui
Journal:  Aging (Albany NY)       Date:  2020-06-11       Impact factor: 5.682

3.  Integrin beta 4 (ITGB4) and its tyrosine-1510 phosphorylation promote pancreatic tumorigenesis and regulate the MEK1-ERK1/2 signaling pathway.

Authors:  Xiangli Meng; Peng Liu; Yunhao Wu; Xinlu Liu; Yinpeng Huang; Boqiang Yu; Jiahong Han; Haoyi Jin; Xiaodong Tan
Journal:  Bosn J Basic Med Sci       Date:  2020-02-05       Impact factor: 3.363
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.